-
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy
Korst, C. L. B. M., Tahri, S., Duetz, C., Bruins, W. S. C., de Jonge, A. V., de Jong, M. E., Fokkema, C., Smits, F., Groen, K., Verkleij, C. P. M., Frerichs, K. A., Papazian, N., van Duin, M., van Beek, G., Hoogenboezem, R., Baardemans, T., Dal Collo, G., Stoetman, E. C. G., Cosovic, M. & Twickler, I. & 15 others, , 19 Jun 2025, In: Blood. 145, 25, p. 3007-3014 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma
de Jonge, A. V., Bruins, W. S. C., Duetz, C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Kersten, M.-J., Sandberg, Y., van Rijn, R. S., Fijnheer, R., Mutsaers, P., Vergote, V. K. J., Issa, D., Beeker, A., Bilgin, Y. M., Visser, O., van Werkhoven, E., Roemer, M. G. M. & Chamuleau, M. E. D. & 1 others, , 1 Nov 2024, In: Haematologica. 109, 11, p. 3760-3761 2 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
In 't Hout, F. E. M., Scheele, T. N., Westers, T. M., Alhan, C., Duetz, C., Cremers, E. M. P., Visser-Wisselaar, H. A., Verbrugge, A., Chitu, D. A., Van der Reijden, B. A., De Graaf, A. O., Jansen, J. H. & van de Loosdrecht, A. A., 10 Oct 2024, (E-pub ahead of print) In: Haematologica.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
